Table S1 from Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer
收藏Figshare2016-10-01 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_S1_from_Phosphoproteomics_Reveals_MAPK_Inhibitors_Enhance_MET-_and_EGFR-Driven_AKT_Signaling_in_i_KRAS_i_-Mutant_Lung_Cancer/22514103
下载链接
链接失效反馈官方服务：
资源简介：
Table S1. List of phosphopeptides identified by phosphoproteomics experiments in A427 and A549 cell line treated with vehicle control (DMSO) or MEK inhibitor (selumetinib)
创建时间：
2016-10-01
